IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,364,443 | +11.3% | 228,493 | +0.9% | 3.08% | +57.1% |
| Q2 2023 | $9,311,128 | +42.5% | 226,493 | +23.9% | 1.96% | -10.5% |
| Q1 2023 | $6,532,307 | +17.5% | 182,773 | +22.8% | 2.19% | +4.1% |
| Q4 2022 | $5,557,941 | -15.6% | 148,807 | 0.0% | 2.11% | -11.9% |
| Q3 2022 | $6,589,000 | -1.2% | 148,807 | -17.4% | 2.39% | +8.4% |
| Q2 2022 | $6,668,000 | -0.0% | 180,107 | 0.0% | 2.21% | +49.8% |
| Q1 2022 | $6,671,000 | -65.3% | 180,107 | -71.4% | 1.48% | -61.4% |
| Q4 2021 | $19,246,000 | – | 630,199 | – | 3.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |